Hikma Pharma says US FDA lifts warning on Eatontown facility
April 02, 2014 at 02:49 AM EDT
April 2 (Reuters) - Hikma Pharmaceuticals Plc said on Wednesday that the U.S. Food and Drug Administration had lifted the warning on its Eatontown facility in New Jersey where it makes oral products for the U.S. market.
